【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Inborn Gene or Chromosome Alterations Overview 11
3 Products under Development 12
3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 12
3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory 13
3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 14
3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 15
3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials 16
4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies 17
4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 17
4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development 20
5 Inborn Gene or Chromosome Alterations Companies and Product Overview 23
5.1 AC-Gen Reading Life S.L. Company Overview 23
5.1.1 AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview 23
5.2 Admera Health, LLC Company Overview 24
5.2.1 Admera Health, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.3 Agena Bioscience, Inc Company Overview 25
5.3.1 Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Ariosa Diagnostics, Inc. Company Overview 29
5.4.1 Ariosa Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.5 Atomic International Company Overview 30
5.5.1 Atomic International Pipeline Products & Ongoing Clinical Trials Overview 30
5.6 Baylor College of Medicine Company Overview 31
5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 31
5.7 BCML GmbH Company Overview 33
5.7.1 BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview 33
5.8 BioCeps (Inactive) Company Overview 34
5.8.1 BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
5.9 CardioDx, Inc. Company Overview 35
5.9.1 CardioDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.10 Celera Corporation Company Overview 37
5.10.1 Celera Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 Celula, Inc. Company Overview 41
5.11.1 Celula, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Children’s Hospital Boston Company Overview 42
5.12.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 China Medical Technologies, Inc. Company Overview 45
5.13.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.14 Da An Gene Co., Ltd. Company Overview 48
5.14.1 Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
5.15 Dana-Farber Cancer Institute, Inc. Company Overview 51
5.15.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.16 Epinex Diagnostics Incorporated Company Overview 53
5.16.1 Epinex Diagnostics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 53
5.17 Genentech, Inc. Company Overview 54
5.17.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.18 German Cancer Research Center Company Overview 55
5.18.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 55
5.19 GILUPI Nanomedizin Company Overview 57
5.19.1 GILUPI Nanomedizin Pipeline Products & Ongoing Clinical Trials Overview 57
5.20 Hadassah Medical Center Company Overview 58
5.20.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 58
5.21 Helicos BioSciences Corporation Company Overview 59
5.21.1 Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
5.22 Illumina, Inc. Company Overview 60
5.22.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.23 IntegraGen SA Company Overview 62
5.23.1 IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview 62
5.24 Interleukin Genetics, Inc. Company Overview 64
5.24.1 Interleukin Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.25 JS Genetics Inc. Company Overview 66
5.25.1 JS Genetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.26 Laboratory Corporation of America Holdings Company Overview 67
5.26.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 67
5.27 Laval University Company Overview 69
5.27.1 Laval University Pipeline Products & Ongoing Clinical Trials Overview 69
5.28 LifeCodexx AG Company Overview 70
5.28.1 LifeCodexx AG Pipeline Products & Ongoing Clinical Trials Overview 70
5.29 Maastricht University Medical Center Company Overview 71
5.29.1 Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 71
5.30 Massachusetts Eye and Ear Infirmary Company Overview 72
5.30.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 72
5.31 Medical Research Council Company Overview 74
5.31.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 74
5.32 Micromedic Technologies Ltd Company Overview 75
5.32.1 Micromedic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
5.33 Multiplicom N.V. Company Overview 76
5.33.1 Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 Myriad Genetics, Inc. Company Overview 78
5.34.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.35 Natera, Inc. Company Overview 80
5.35.1 Natera, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.36 National University of Singapore Company Overview 85
5.36.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 85
5.37 NewGene Ltd Company Overview 89
5.37.1 NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
5.38 NX PharmaGen Inc. Company Overview 94
5.38.1 NX PharmaGen Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.39 Paragon Medical, Inc. Company Overview 95
5.39.1 Paragon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.40 Population Diagnostics Inc. Company Overview 96
5.40.1 Population Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.41 Qiagen N.V. Company Overview 100
5.41.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 100
5.42 Quantamerix Company Overview 102
5.42.1 Quantamerix Pipeline Products & Ongoing Clinical Trials Overview 102
5.43 Sapien Biosciences Company Overview 103
5.43.1 Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview 103
5.44 Seegene, Inc. Company Overview 104
5.44.1 Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.45 Sequenom, Inc. Company Overview 106
5.45.1 Sequenom, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.46 Stanford University Company Overview 112
5.46.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 112
5.47 The Johns Hopkins University Company Overview 114
5.47.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 114
5.48 The Sheba Medical Center Company Overview 115
5.48.1 The Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 115
5.49 The University of Utah Company Overview 116
5.49.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 116
5.50 TrovaGene, Inc. Company Overview 117
5.50.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.51 University of Colorado Company Overview 121
5.51.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 121
5.52 University of Washington Company Overview 122
5.52.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 122
5.53 VitaPath Genetics, Inc. Company Overview 123
5.53.1 VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 Xiamen Zeesan Biotech Co.,Ltd Company Overview 124
5.54.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 124
5.55 Yale University Company Overview 125
5.55.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 125
6 Inborn Gene or Chromosome Alterations- Recent Developments 126
7 Appendix 165
7.1 Methodology 165
7.2 About GlobalData 167
7.3 Contact Us 168
7.4 Disclaimer 168
【レポート販売概要】
■ タイトル：世界における先天的遺伝子変異または先天的染色体変異検査製品のパイプライン動向2015■ 英文：Inborn Gene or Chromosome Alterations - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0076EPD
■ 調査対象地域：グローバル
- 高性能セラミックコーティング剤の世界市場：製品種類別（酸化物コーティング、炭化物コーティング、窒化物コーティング）、技術別（サーマルスプレー、物理蒸着、化学蒸着、およびその他のテクノロジー）、エンドユーズ産業別（自動車、航空宇宙および防衛、一般産業用ツールおよび機械、ヘルスケア、その他）The global high performance ceramic coatings market was valued at $7,844.0 million in 2018 and is projected to reach $12,633.3 million by 2026, growing at a CAGR of 6.2% from 2019 to 2026. High performance ceramic coatings are inorganic materials which are treated and used at high temperatures. These coatings are applied on automotive engine components, which increases the fuel efficiency. Its phy …
- 韓国の石油・ガス産業における中流（Midstream）市場展望South Korea Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing Summary "South Korea Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in South Korea. The report …
- 世界のクラウドサービス仲介市場動向（2014-2018）TechNavio's analysts forecast the Global Cloud Services Brokerage market to grow at a CAGR of 45.90 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing complexity in integrating cloud-based solutions with enterprise computing infrastructure. The Global Cloud Services Brokerage market has also been witnessing the standardization of cloud-ba …
- グリーンキレート/天然キレート剤の世界市場：グルコン酸ナトリウム、EDDS、MGDA、GLADThe market size of green chelates/natural chelating agents is projected to reach USD 2.45 Billion by 2021, registering a CAGR of 5.74% between 2016 and 2021. The increasing demand for green chelates/natural chelating agents from end-use applications such as cleaning, water treatment, agriculture, personal care, and food & beverage owing to its superior properties and eco-friendliness is the major …
- 家庭用調理機器の世界市場分析：製品別[クッキングトップ･クッキングレンジ（ガス、電気、IH）; オーブン（従来型、マイクロ波、混合型）; 専門家電]、地域別、セグメント予測、2014 – 2024The global household cooking appliances market size is anticipated to reach USD 116.82 billion by 2024, according to a new report by Grand View Research, Inc. A blend of numerous aspects such as increasing preference toward nuclear family set-ups, a high proportion of employed women, and induction technology being characterized by a higher degree of energy-efficiency as compared to conventional ga …
- 世界及び中国のルーツ送風機市場2015< China & Global Roots Blower Market 2015> is a professional and deep research report in this field. For overview analysis, the report introduces Roots Blower basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Roots Blower markets …
- 世界のアップストリーム開発動向：（石油・ガス開発）上位100アップストリーム資産Top 100 Global Upstream Developments Overview - Major Project Developments and Key Challenges Summary Upstream oil and gas assets play a major role in satisfying the world’s energy needs, and are located around the world in both onshore and offshore regions and in challenging conditions such as ultra-deep waters and freezing temperatures. Production is therefore technologically complex and necessi …
- Fungemia：グローバル臨床試験レビューH2, 2013Fungemia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2013" provides data on the Fungemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fungemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- Electricite du Liban：発電所及び企業SWTO分析2015Electricite du Liban - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized an …
- アジア太平洋の教育用パソコン市場：デスクトップ、ノートパソコン、タブレットAbout the Education PC Market In the past few years, the use of PCs has increased because of the evolution of learning and teaching methodology. Educational institutions are developing innovative teaching methods and relevant IT tools for students and staff for improved efficiencies and learning processes. Increased demand for computers can be attributed to the high dependency on digitized educati …
- アルゼンチンの水力発電市場2016：発電能力、生産、投資動向、制度、企業Hydropower in Argentina, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Hydropower in Argentina, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry …
- 世界の3D薄型テレビ市場動向（2014～2018）TechNavio's analysts forecast the Global 3D Flat Panel TV market to grow at a CAGR of 15.4 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in 3D content broadcasts. The Global 3D Flat Panel TV market has also been witnessing the emergence of 4K resolution technology. However, the health risk associated with 3D technology could pose a cha …
- 自己血輸血装置・消耗品の世界市場：製品種類別（デバイス、消耗品）、エンドユーズ別（病院、外来手術セッティング、その他）Autotransfusion is a process of blood transfusion where the blood of the patient is extracted from the site of wound, which then gets filtered and purified. This blood is then infused back to the patients’ body. Autotransfusion is used in several surgeries such as cardiovascular surgery, orthopedic surgeries, surgeries related to trauma and during liver and other types of transplantation. The glob …
- German Hospital Clinical Chemistry and Immunodiagnostics Market 2014This new report from Venture Planning Group contains 523 pages, 64 tables, and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with sign …
- 屋内位置情報ソリューションの世界市場：タグ型、RF型、センサー型ソリューションIn recent years, there has been a substantial demand for indoor positioning and navigation equipment in the marketplace across verticals. The demand is surging in those industries that were early indoor location adopters. With potential opportunities in emerging verticals, there is a good investment that is being done in the indoor location research, development, and innovation by the majority of …
